Bank of America’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,956
| Closed | -$146K | – | 8058 |
|
|
2020
Q4 | $146K | Buy |
7,956
+4,522
| +132% | +$82.4K | ﹤0.01% | 5794 |
|
|
2020
Q3 | $63K | Sell |
3,434
-2,081
| -38% | -$35K | ﹤0.01% | 5922 |
|
|
2020
Q2 | $83K | Buy |
5,515
+2,367
| +75% | +$33.8K | ﹤0.01% | 5769 |
|
|
2020
Q1 | $50K | Sell |
3,148
-1,783
| -36% | -$28.8K | ﹤0.01% | 5876 |
|
|
2019
Q4 | $80K | Sell |
4,931
-482
| -9% | -$8.04K | ﹤0.01% | 6094 |
|
|
2019
Q3 | $80K | Buy |
5,413
+778
| +17% | +$10.5K | ﹤0.01% | 6149 |
|
|
2019
Q2 | $77K | Buy |
4,635
+1,995
| +76% | +$32.6K | ﹤0.01% | 6121 |
|
|
2019
Q1 | $46K | Sell |
2,640
-7,808
| -75% | -$142K | ﹤0.01% | 6232 |
|
|
2018
Q4 | $185K | Buy |
10,448
+7,054
| +208% | +$120K | ﹤0.01% | 5569 |
|
|
2018
Q3 | $61K | Buy |
3,394
+1,542
| +83% | +$31.6K | ﹤0.01% | 6128 |
|
|
2018
Q2 | $37K | Sell |
1,852
-1,501
| -45% | -$28.1K | ﹤0.01% | 6294 |
|
|
2018
Q1 | $59K | Buy |
+3,353
| New | +$61.4K | ﹤0.01% | 5975 |
|
|
2017
Q3 | – | Sell |
-3,206
| Closed | -$28K | – | 7379 |
|
|
2017
Q2 | $28K | Buy |
3,206
+1,052
| +49% | +$9.27K | ﹤0.01% | 6115 |
|
|
2017
Q1 | $25K | Buy |
2,154
+384
| +22% | +$4.66K | ﹤0.01% | 6234 |
|
|
2016
Q4 | $23K | Buy |
1,770
+1,106
| +167% | +$14.8K | ﹤0.01% | 6302 |
|
|
2016
Q3 | $9K | Buy |
664
+335
| +102% | +$4.75K | ﹤0.01% | 6441 |
|
|
2016
Q2 | $4K | Buy |
+329
| New | +$5.28K | ﹤0.01% | 6759 |
|
|
2016
Q1 | – | Sell |
-238
| Closed | -$5K | – | 7467 |
|
|
2015
Q4 | $5K | Buy |
238
+190
| +396% | +$4.02K | ﹤0.01% | 6896 |
|
|
2015
Q3 | $1K | Sell |
48
-224
| -82% | -$5.57K | ﹤0.01% | 7081 |
|
|
2015
Q2 | $10K | Buy |
+272
| New | +$8.78K | ﹤0.01% | 6601 |
|
|
2014
Q4 | – | Sell |
-502
| Closed | -$11K | – | 8091 |
|
|
2014
Q3 | $11K | Buy |
+502
| New | +$10.2K | ﹤0.01% | 7299 |
|
Bank of America's CBMG Position: Q1 2021 in Review
Bank of America sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 7,956 shares — an estimated $146K sold.
Bank of America first reported a position in CBMG in Q3 2014 and held it in 21 quarters. The position peaked at $185K in Q4 2018. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.
- Bank of America reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
- Bank of America sold 7,956 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $146K.
- Bank of America first reported a position in Cellular Biomedicine Group, Inc. in Q3 2014 and held it in 21 quarters.
- Bank of America's Cellular Biomedicine Group, Inc. position peaked at $185K in Q4 2018.
- 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.
Based on Bank of America's 13F filing for Q1 2021, filed 14 May 2021.